X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Global Hematologic Malignancies Treatment Companies

This report lists the top Global Hematologic Malignancies Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Hematologic Malignancies Treatment industry.

Global Hematologic Malignancies Treatment Top Companies

  1. Pfizer, Inc.

  2. F. Hoffmann-LA Roche ltd

  3. AbbVie, Inc.

  4. Bristol-Myers Squibb Company

  5. Sanofi S.A

*Disclaimer: Top companies sorted in no particular order

 Global Hematologic Malignancies Treatment Market Major Players

Global Hematologic Malignancies Treatment Market Concentration

Global Hematologic Malignancies Treatment Market Concentration

Global Hematologic Malignancies Treatment Company List

                              • Pfizer Inc.

                              • F. Hoffmann-LA Roche Ltd

                              • Sanofi SA

                              • Bristol-Myers Squibb Company

                              • AbbVie Inc.

                              • Novartis AG

                              • GlaxoSmithKline PLC

                              • Amgen Inc.

                              • Takeda Pharmaceutical Co. Ltd

                              • Johnson & Johnson

                              • Incyte Corporation

                              • AstraZeneca PLC

                              • Celldex Therapeutics Inc.

                              • Kite Pharma (Gilead Sciences)

                              • Atara Biotherapeutics


                          Specific to Global Hematologic Malignancies Treatment Market
                          Need More Details On Market Players And Competitors?
                          Download Sample

                          Hematologic Malignancies Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)